Severity: Notice
Message: Undefined index: HTTP_ACCEPT_LANGUAGE
Filename: controllers/Main.php
Line Number: 40
Backtrace:
File: /var/www/html/php-7-4-3/venuspharmagmbh-de/application/controllers/Main.php
Line: 40
Function: _error_handler
File: /var/www/html/php-7-4-3/venuspharmagmbh-de/application/controllers/Main.php
Line: 20
Function: getlocallangauage
File: /var/www/html/php-7-4-3/venuspharmagmbh-de/index.php
Line: 315
Function: require_once
Venus Pharma GmbH offers EU CTD Dossiers not only for the German pharmaceutical market but for complete Europe & other regulated markets. We offer pharmaceutical manufacturing services for a varied range of products.
More
With the assistance of our GLP accredited Research unit, Venus Medicine Research Center, we are leading the German pharmaceutical sector by promoting and practising research-backed pharmaceutical manufacturing.
More
We offer a batch release facility of pharmaceutical formulations along with testing in our laboratories. Product testing at multiple levels ensures the quality and makes us the highly recommended pharmaceutical manufacturer in Europe.
More
Venus Pharma GmbH is one of the leading pharmaceutical manufacturers in Germany offering commercial development & manufacturing. As a top pharmaceutical manufacturer in Europe, we develop and manufacture generic products.
More
Venus Pharma GmbH is equipped with a dedicated packaging area for Cephalosporins and Oncology. Venus Remedies Europe offers an error-free, quality, customized, and cost-effective packaging facility for a variety of pharma products.
More
Top pharmaceutical manufacturers in Germany provide a warehouse and logistics facility along with manufacturing, and VPG is one among them. Warehousing is an area of expertise for VPG. The company owns & operates a 3200 pallet storage capacity warehouse.
More
Venus Remedies embraces GPTW certification for the third time in a row - exemplifying the Diversity, Equity, and Inclusion principles.
Venus Remedies embraces GPTW certification for the third time in a row - exemplifying the Diversity, Equity, and Inclusion principles.
Venus Remedies receives regulatory approvals for Paclitaxel, Zoledronic Acid, and Bleomycin from the Philippines & Saudi Arabia.
Venus Remedies secures marketing authorization for Enoxaparin in Azerbaijan, a strategic move to tap into a $850 million pharmaceutical market.
Venus enters Ukraine as a major step towards combating cancer in the country
Venus received Good Manufacturing Practices Certification from Kenya Pharmacy & Poisons Board
Venus received new registration of Meropenem in Spain
Venus Pharma GmbH, the German subsidiary of Venus Remedies Limited, has recently received a registration certificate from the UK (MHRA) for its chemotherapy drug, Cisplatin.
Venus Remedies Limited and Venus Pharma GmbH successfully exhibited at the CPhI Frankfurt 2022 event, which took place from 1st to 3rd November.
Hub for multiple business models- Tech Transfer, In-Licensing, Out-Licensing, Product development, Site Variation, Packaging, Warehousing and Batch Release.
Venus Remedies Europe successfully completed 10 years of being in the EU market. It's all about the intellectual capital that is our primary business driver.
Meropenem became our prime product in EU with supply of more than 4.5 Million vials. Established Gemcitabine in UK with NHS Tenders’ supply.
Launched our Anti-cancer & Anti-biotics in the markets of Germany & UK.
Established footprints in the prime markets of Middle East with focus on Syria.
Entered the German pharmaceutical space with the acquisition of a Manufacturing Plant at Werne, Germany, and transformed it to “VENUS PHARMA GmbH”.
